Next Article in Journal
Screen Printed Carbon Electrode Based Electrochemical Immunosensor for the Detection of Dengue NS1 Antigen
Next Article in Special Issue
Evaluation of the Diagnostic Accuracy of Serum D-Dimer Levels in Pregnant Women with Adnexal Torsion
Previous Article in Journal
Spectro-Fluor™ Technology for Reliable Detection of Proteins and Biomarkers of Disease: A Pioneered Research Study
Open AccessReview

Current Challenges Towards the Development of a Blood Test for Parkinson’s Disease

The Cellular and Molecular Pharmacology Department, The Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL 60064-3037, USA
*
Author to whom correspondence should be addressed.
Diagnostics 2014, 4(4), 153-164; https://doi.org/10.3390/diagnostics4040153
Received: 9 September 2014 / Revised: 8 October 2014 / Accepted: 11 October 2014 / Published: 22 October 2014
(This article belongs to the Special Issue Biomarkers in Blood)
Parkinson’ disease (PD) is the second most prevalent neurodegenerative disease worldwide. To date, there is no disease-modifying agent, and current medical treatment only provides symptomatic benefits. Early diagnosis of PD would be useful in clinical practice to identify patients for clinical trials, test potential drugs and neuroprotective agents and track their therapeutic effect. Considerable progress has been made in the discovery and validation of diagnostic biomarkers for PD. In particular, blood-based biomarkers have shown promise in identifying PD patients in samples from independent clinical trials. Evaluation of these biomarkers in de novo patients and individuals at risk for PD remains a top priority. Here, we review the current advances and challenges toward the clinical translation of these biomarkers into a blood-based test for PD. View Full-Text
Keywords: biomarkers; blood; Parkinson’s disease biomarkers; blood; Parkinson’s disease
MDPI and ACS Style

Santiago, J.A.; Potashkin, J.A. Current Challenges Towards the Development of a Blood Test for Parkinson’s Disease. Diagnostics 2014, 4, 153-164.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop